Novavax, Inc. NMS · NVAX

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

The Motley Fool · 69d ago

What's Going On With Novavax Stock On Friday?

Benzinga · 74d ago

This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy?

The Motley Fool · 173d ago

Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer

The Motley Fool · 176d ago

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

Benzinga · 298d ago

FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects

Benzinga · 314d ago

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency

Benzinga · 343d ago

Moderna's mRNA Flu Vaccine Outperforms Standard Shots

Benzinga · 386d ago

Vaccine Adjuvants Market to Reach USD 5.43 Billion by 2032 Due to Increasing Demand for Enhanced Vaccine Efficacy and Global Immunization Programs – SNS Insider

GlobeNewswire Inc. · 387d ago

Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals

Benzinga · 414d ago

Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children

Benzinga · 420d ago

Analysts Think These Stocks Could More Than Double in Value

Investing.com · 424d ago

Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?

Benzinga · 482d ago

Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider

GlobeNewswire Inc. · 523d ago

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch

Benzinga · 526d ago

Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?

The Motley Fool · 551d ago

Is Biotech’s Bull Run Over? Examining Election Impacts

Investing.com · 606d ago

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm

GlobeNewswire Inc. · 630d ago

This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?

The Motley Fool · 638d ago

How Bad Is This News for Novavax?

The Motley Fool · 640d ago

Should You Buy Novavax Stock After This Regulatory Win?

The Motley Fool · 676d ago

2024 Market Research: Vaccines Market Projected to Reach USD 116.63 Billion by 2027 - Rising Disease Prevalence and Prophylactic Applications Fueling Growth

GlobeNewswire Inc. · 683d ago

Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?

The Motley Fool · 684d ago

Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?

The Motley Fool · 696d ago

Novavax Unusual Options Activity - Benzinga

Benzinga · 732d ago